Summary of STERIS plc (NYSE:STE) Ratings as of Jun 27, 2018

June 27, 2018 - By Don Salinas

STERIS plc (NYSE:STE) Corporate Logo
Big Money Sentiment increased to 0.33 in Q1 2018. It has change of 0.16, from 2017Q4’s 0.17. The ratio increased due to STERIS plc positioning: 2 sold and 1 reduced. 1 funds amassed stakes and 0 increased stakes. Investors holded 19,649 in 2017Q4 but now own 21,503 shares or 9.44% more.
Alphamark Advsr Lc invested in 0.01% or 150 shs. Fruth Investment Mgmt owns 0.55% invested in STERIS plc (NYSE:STE) for 13,276 shs. Prudential Public Limited Co invested 0% in STERIS plc (NYSE:STE). 4,277 are owned by Eqis Capital Management Inc.

STERIS plc (NYSE:STE) Ratings Coverage

In total 3 analysts cover STERIS (NYSE:STE). “Buy” rating has 2, “Sell” are 0, while 1 are “Hold”. (NYSE:STE) has 67% bullish analysts. 3 are the (NYSE:STE)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. The stock rating was downgraded by Raymond James to “Market Perform” on Wednesday, January 3. On Thursday, February 8 Northcoast maintained the shares of STE in report with “Buy” rating. On Thursday, February 8 the firm has “Buy” rating given by KeyBanc Capital Markets. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

Ticker’s shares touched $105.09 during the last trading session after 0.32% change.STERIS plc has volume of 316,343 shares. Since June 27, 2017 STE has risen 34.02% and is uptrending. STE outperformed the S&P 500 by 21.45%.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The firm is worth $8.89 billion. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 37.02. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s a substantial STERIS plc (NYSE:STE) news released by It’s an article titled: “Research Report Identifies STERIS plc, Parker-Hannifin, Sturm, Ruger, CoBiz Financial, Black Hills, and Glacier with …” on June 22, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.